Rehabilitation for Head and Neck Cancer

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 1, 2017

Study Completion Date

April 1, 2017

Conditions
Head and Neck Neoplasms
Interventions
BEHAVIORAL

Exercise and nutrition during radiotherapy

The intervention consists of physical exercise, nutritional counselling and supplements. The exercise sessions will be conducted twice a week for 30 minutes each time during the RT treatment period, and include a main part of progressive resistance training (PRT). The PRT will be conducted by conventional upper and lower body exercises at a load of 60 - 80 % of 1 repetition maximum (RM) in 3-4 sets of 6-12 repetitions. The patients will receive nutritional information and dietary advice, and up to 2 energy dense oral nutritional supplements (ONS) daily. A nutrition interview will be conducted at study baseline and individual goals and targets will be set during the first counselling and monitored during the intervention period.

BEHAVIORAL

Multidimensional rehabilitation after radiotherapy

The intervention consists of physical exercise, nutritional counselling and supplements and patient education. The exercise sessions will be conducted 3 times a week for 45 minutes each time during the 3 week rehabilitation programme, and include a main part of progressive resistance training (PRT). PRT will be conducted as described in the intervention during treatment. The nutritional intervention will be carried out as described in the intervention during treatment. Patient education will be run as 45-60 minutes lecture/group discussion on relevant topics, lead by health professionals.

Trial Locations (2)

7374

LHL-klinikkene Røros, Røros

Unknown

St Olavs Hospital, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

collaborator

LHL-Klinikkene, Røros

OTHER

collaborator

Oslo University Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT02439892 - Rehabilitation for Head and Neck Cancer | Biotech Hunter | Biotech Hunter